Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bisphosphonate actions on cancer.

T Yoneda1, N Hashimoto, T Hiraga

  • 1Department of Biochemistry, Department of Medicine, Osaka University Graduate School of Dentistry, Japan and Endocrine Research, The University of Texas Health Science Center at San Antonio, Texas, USA. yoneda@uthscsa.edu

Calcified Tissue International
|July 23, 2003
PubMed
Summary

Bisphosphonates (BPs) show benefit in treating bone metastases but are not recommended for visceral metastases without bone involvement. Their direct anti-cancer effects in non-bone sites require further investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Superficial temporal artery to anterior cerebral artery direct anastomosis in patients with moyamoya disease.

Clinical neurology and neurosurgery·1997
Same author

Mechanism of intracranial rebleeding in moyamoya disease.

Clinical neurology and neurosurgery·1997
Same author

Direct surgery for major artery aneurysm associated with moyamoya disease.

Clinical neurology and neurosurgery·1997
Same author

A novel myeloid cell line, Marimo, derived from therapy-related acute myeloid leukemia during treatment of essential thrombocythemia: consistent chromosomal abnormalities and temporary C-MYC gene amplification.

Cancer genetics and cytogenetics·1997
Same author

Platelet-derived growth factor-BB, but not -AA, prevents delayed neuronal death after forebrain ischemia in rats.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·1997
Same author

Characteristics of protein kinase C-independent exocytosis in human platelets.

Thrombosis research·1997

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • Bisphosphonates (BPs) are known to suppress cancer cell colonization in bone.
  • Their mechanism is primarily attributed to inhibiting osteoclastic bone resorption, which limits the release of growth factors supporting cancer cells.
  • Emerging data suggest BPs may also directly impact cancer cell survival independently of osteoclasts.

Purpose of the Study:

  • To review the effectiveness of BPs on breast cancer colonization in non-bone sites.
  • To discuss findings from animal models regarding BP efficacy in metastases.
  • To evaluate the current clinical evidence for BPs in non-bone cancer progression.

Main Methods:

  • Literature review of clinical data on Bisphosphonates (BPs) and cancer.

Related Experiment Videos

  • Analysis of in vivo experimental results from animal models with metastases.
  • Synthesis of evidence regarding BP effects on cancer cell survival and tumor growth.

    • Main Results:

    • BPs are clinically beneficial for patients with detectable bone metastases.
    • Evidence is limited for BP efficacy in reducing tumor growth at non-bone sites.
    • Current data do not support preventative use of BPs for visceral metastases without bone involvement.

    Conclusions:

    • Bisphosphonates (BPs) are established treatments for bone metastases.
    • The direct anti-cancer effects of BPs in non-bone sites require further research.
    • The potential for unique actions among different Bisphosphonates (BPs) remains an open question.